SASSI, VALENTINA ALBA
SASSI, VALENTINA ALBA
Universita' degli Studi di MILANO
Impact of Sacubitril/Valsartan on surfactant binding proteins, central sleep apneas, lung function tests and heart failure biomarkers: Hemodynamic or pleiotropism?
2022 M. Mapelli, I. Mattavelli, E. Salvioni, C. Banfi, S. Ghilardi, F. De Martino, P. Gugliandolo, V. Mantegazza, V. Volpato, C. Basile, M.I.F. Branco Pires, V. Sassi, B. Nusca, C. Vignati, M. Contini, C. Sforza, M.L. Biondi, P. Perrone Filardi, P. Agostoni
Cardiac reverse remodelling by 2d and 3d echocardiography in heart failure patients treated with sacubitril/valsartan
2021 V. Mantegazza, V. Volpato, M. Mapelli, V. Sassi, E. Salvioni, I. Mattavelli, G. Tamborini, P. Agostoni, M. Pepi
Early cardiac reverse remodeling in a large cohort of patients with HFrEF treated with Sacubitril/Valsartan
2020 M. Mapelli, E. Salvioni, I. Mattavelli, V. Sassi, V. Mantegazza, V. Volpato, C. Vignati, F. De Martino, S. Paolillo, L. Fusini, M. Muratori, M. Pepi, P. Agostoni
Sacubitril/Valsartan use in a real world experience : data from a large single-center population of heart failure patients with reduced ejection fraction
2020 M. Mapelli, E. Salvioni, I. Mattavelli, V. Sassi, P. Gugliandolo, V. Mantegazza, V. Volpato, C. Vignati, F. De Martino, S. Paolillo, M. Contini, A. Apostolo, M. Magini, P. Palermo, P. Agostoni
Effects of Sacubitril/Valsartan on exercise capacity, natriuretic peptides and ventricular remodeling in a prospective cohort of patients with heart failure and reduce ejection fraction
2020 M. Mapelli, E. Salvioni, I. Mattavelli, V. Sassi, F. De Martino, S. Paolillo, V. Mantegazza, V. Volpato, C. Vignati, A. Magini, A. Apostolo, P. Palermo, P. Agostoni
Sacubitril/valsartan use in a real-world population of patients with heart failure and reduced ejection fraction
2020 M. Mapelli, E. Salvioni, F. de Martino, I. Mattavelli, A. Bonomi, V. Sassi, P. Gugliandolo, C. Vignati, A. Magini, S. Rovai, S. Paolillo, P. Agostoni
Sacubitril/valsartan use in a real world experience: data from a large single-center population of heart failure patients with reduced ejection fraction
2019 M. Mapelli, E. Salvioni, I. Mattavelli, V. Sassi, P. Gugliandolo, V. Mantegazza, V. Volpato, C. Vignati, F. De Martino, S. Paolillo, M. Contini, A. Apostolo, A. Magini, P. Palermo, P. Agostoni
Effects of sacubitril/Valsartan on exercise capacity, natriuretic peptides and ventricular remodelling in a prospective cohort of patients with heart failure and reduced ejection fraction
2019 M. Mapelli, E. Salvioni, I. Mattavelli, V. Sassi, F. De Martino, S. Paolillo, V. Mantegazza, V. Volpato, C. Vignati, A. Magini, P. Palermo, A. Apostolo, P. Agostoni
Early cardiac reverse remodelling in a large cohort of patients with HFrEF treated with Sacubitril/Valsartan
2019 M. Mapelli, E. Salvioni, I. Mattavelli, V. Sassi, V. Mantegazza, V. Volpato, C. Vignati, F. De Martino, S. Paolillo, L. Fusini, M. Muratori, M. Pepi, P. Agostoni